SAR-110894
- Generic Name
- SAR-110894
Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Phase 2
Completed
- Conditions
- Dementia Alzheimer's Type
- Interventions
- First Posted Date
- 2010-12-24
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 291
- Registration Number
- NCT01266525
- Locations
- 🇺🇸
Investigational Site Number 840024, Costa Mesa, California, United States
🇺🇸Investigational Site Number 840041, Gilbert, Arizona, United States
🇵🇱Investigational Site Number 616004, Bydgoszcz, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath